ST百灵 (002424)
Guizhou Bailing Group Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Company NameGuizhou Bailing Enterprise Group Pharmaceutical Co., Ltd.
Listing Date2010-06-03
Issue Price40Yuan
Registered Capital139759.8410K Yuan
Legal RepresentativeJiang Wei
Registered AddressNo. 212 Xihang Road, Economic and Technological Development Zone, Anshun City, Guizhou Province
IndustryTraditional Chinese Medicine II
Main BusinessProduction and sales of Chinese patent medicines primarily based on Miao ethnic medicine.
Company ProfileGuizhou Bailing Enterprise Group Pharmaceutical Co., Ltd. is a listed pharmaceutical company engaged in the research and development, production, and sales of Miao ethnic medicine. It has been awarded numerous honors, including 'National Intellectual Property Advantage Enterprise', 'National Recognized Enterprise Technology Center', 'Innovative Enterprise', 'National Contract-Honoring and Creditworthy Enterprise', 'Top 50 Private Enterprises in Guizhou', Top 100 in the Pharmaceutical Industry, Top 20 Chinese Listed Pharmaceutical Companies in 2015, Top 100 Chinese Pharmaceutical Manufacturers in 2016, and the inaugural 'Governor's Quality Award' of Guizhou Province in 2016.
Stock Details
1. Key Indicators
- Total Shares(W): 139759.84
- Circulating A-Shares(W): 121321.45
- Earnings Per Share(RMB): 0.0400
- Net Assets Per Share(RMB): 2.3348
- Operating Revenue(W RMB): 210157.59
- Total Profit(W RMB): 12897.81
- Net Profit Attributable to Parent(W RMB): 5681.44
- Net Profit Growth Rate(%): -35.60
- Weighted Return on Equity(%): 1.7700
- Operating Cash Flow Per Share(RMB): 0.3830
- Undistributed Profit Per Share(RMB): 1.1476
- Capital Reserve Per Share(RMB): 0.0805
2. Main Business
The main business covers:
- Miao medicine research, production, and sales
3. Company Basic Information
- Company Name: Guizhou Bailing Group Pharmaceutical Co., Ltd.
- Listing Date: 2010-06-03
- Industry: Pharmaceutical Manufacturing
- Address: No. 212 Xihang Road, Economic and Technological Development Zone, Anshun City, Guizhou Province
- Website: www.gzbl.com
- Company Profile: The Company was established by Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd. by converting its audited net assets of RMB 149,775,944.18 as of October 31, 2007 into 110 million shares at a ratio of 1:0.7344, with the remaining RMB 39,775,944.18 converted into capital reserve, thereby transforming into a joint stock company. Chongqing Tianjian issued the Chong Tianjian Yan [2007] No. 72 "Capital Verification Report" for the above-mentioned capital contribution, verifying that the contributions of all promoters of the joint stock company had been fully paid. On December 26, 2007, the Anshun Administration for Industry and Commerce issued the "Business License" for the Company.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Huachuang Securities - Securities Industry Support for Private Enterprise Development Series Huachuang Securities No.1 FOF Single Asset Management Plan - Huachuang Securities Co., Ltd. Support for Private Enterprise Development No.14 Single Asset Management Plan | Asset Management Plan | 8680.55 | 7.16 |
| 2 | Huachuang Securities - ICBC - Huachuang Securities Co., Ltd. Support for Private Enterprise Development No.1 Collective Asset Management Plan | General Legal Person | 7454.10 | 6.14 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 1407.33 | 1.16 |
5. Concept Sectors
- ST Sector
- Private Hospitals
- Smart Healthcare
- Rural Revitalization
- Tencent Concept
- Industrial Hemp
- Hepatitis Concept
- Innovative Drugs
- AI Healthcare
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information